Announcements Trials

Browse Landscape

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 8 Breast Neoplasms 8 Prostatic Neoplasms 5 Small Cell Lung Carcinoma 4 Stomach Neoplasms 3 Neoplasms 3 Lung Neoplasms 3 Fallopian Tube Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Triple Negative Breast Neoplasms 2 Recurrence 2 Neuroendocrine Tumors 2 Neoplasm Metastasis 2 Glioma 2 Uterine Neoplasms 1 Urogenital Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Synovial 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Diseases 1 Pheochromocytoma 1 Peritoneal Neoplasms 1 Paraganglioma 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms by Site 1 Metastatic Castration-Resistant Prostate Cancer 1 Meningioma 1

Interventions

Temozolomide 26 Bevacizumab 14 Radiosurgery 12 Radiotherapy 9 pembrolizumab 8 Carboplatin 8 Trastuzumab 6 temsirolimus 5 Sirolimus 5 Erlotinib Hydrochloride 5 abemaciclib 4 Paclitaxel 4 Irinotecan 4 Capecitabine 4 tipifarnib 3 Sorafenib 3 Radiation 3 Mental Status and Dementia Tests 3 Ipilimumab 3 Everolimus 3 Aminolevulinic Acid 3 130-nm albumin-bound paclitaxel 3 tucatinib 2 pertuzumab 2 fludarabine 2 durvalumab 2 alovudine 2 alectinib 2 Vorinostat 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Brain Neoplasms × olaparib × Clear all

NCT04711824 2025-12-23

SOLARA

Hoosier Cancer Research Network

Phase 1/2 Recruiting

Brain Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡